首页> 外文期刊>Toxicology and Applied Pharmacology >Time-course comparison of xenobiotic activators of CAR and PPARalpha in mouse liver.
【24h】

Time-course comparison of xenobiotic activators of CAR and PPARalpha in mouse liver.

机译:小鼠肝脏中CAR和PPARalpha的异种生物激活剂的时程比较。

获取原文
获取原文并翻译 | 示例
           

摘要

Constitutive androstane receptor (CAR) and peroxisome proliferator activated receptor (PPAR)alpha are transcription factors known to be primary mediators of liver effects, including carcinogenesis, by phenobarbital-like compounds and peroxisome proliferators, respectively, in rodents. Many similarities exist in the phenotypes elicited by these two classes of agents in rodent liver, and we hypothesized that the initial transcriptional responses to the xenobiotic activators of CAR and PPARalpha will exhibit distinct patterns, but at later time-points these biological pathways will converge. In order to capture the global transcriptional changes that result from activation of these nuclear receptors over a time-course in the mouse liver, microarray technology was used. First, differences in basal expression of liver genes between C57Bl/6J wild-type and Car-null mice were examined and 14 significantly differentially expressed genes were identified. Next, mice were treated with phenobarbital (100 mg/kg by gavage for 24 h, or 0.085% w/w diet for 7 or 28 days), and liver gene expression changes with regards to both time and treatment were identified. While several pathways related to cellular proliferation and metabolism were affected by phenobarbital in wild-type mice, no significant changes in gene expression were found over time in the Car-nulls. Next, we determined commonalities and differences in the temporal response to phenobarbital and WY-14,643, a prototypical activator of PPAR alpha. Gene expression signatures from livers of wild-type mice C57Bl6/J mice treated with PB or WY-14,643 were compared. Similar pathways were affected by both compounds; however, considerable time-related differences were present. This study establishes common gene expression fingerprints of exposure to activators of CAR and PPARalpha in rodent liver and demonstrates that despite similar phenotypic changes, molecular pathways differ between classes of chemical carcinogens.
机译:组成型雄甾烷受体(CAR)和过氧化物酶体增殖物激活受体(PPAR)α是已知是啮齿类动物中苯巴比妥类化合物和过氧化物酶体增殖物分别是肝脏效应(包括致癌作用)的主要介质的转录因子。在啮齿动物肝脏中,这两类药物引起的表型存在许多相似性,我们假设对CAR和PPARalpha的异种生物激活物的初始转录反应将表现出不同的模式,但在稍后的时间点,这些生物学途径将会融合。为了捕获在小鼠肝脏中随时间变化而激活这些核受体而导致的整体转录变化,使用了微阵列技术。首先,检查了C57Bl / 6J野生型和Car-null小鼠之间肝脏基因基础表达的差异,并鉴定了14个显着差异表达的基因。接下来,用苯巴比妥(管饲100 mg / kg,灌胃24 h,或0.085%w / w饮食,灌胃7或28天)治疗小鼠,并鉴定了肝脏基因表达随时间和治疗的变化。虽然在野生型小鼠中苯巴比妥影响了与细胞增殖和代谢相关的几种途径,但在Car-nulls中,随着时间的推移未发现基因表达的明显变化。接下来,我们确定了对苯巴比妥和WY-14643(PPARα的原型激活剂)的时间反应的共性和差异。比较了用PB或WY-14643处理的野生型小鼠C57B16 / J小鼠肝脏的基因表达特征。两种化合物都影响相似的途径。但是,存在大量与时间相关的差异。这项研究建立了暴露于啮齿动物肝脏中CAR和PPARα激活剂的常见基因表达指纹,并证明尽管表型发生了相似的变化,但化学致癌物的分子途径却有所不同。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号